Select a Meeting...
- SHM Converge 2026
- SHM Converge 2025
- SHM Converge 2024
- SHM Converge 2023
- SHM Converge 2022
- SHM Converge 2021
- Hospital Medicine 2020, Virtual Competition
- Hospital Medicine 2019, March 24-27, National Harbor, Md.
- Hospital Medicine 2018; April 8-11; Orlando, Fla.
- Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
- Hospital Medicine 2016, March 6-9, San Diego, Calif.
- Hospital Medicine 2015, March 29-April 1, National Harbor, Md.
- Hospital Medicine 2014, March 24-27, Las Vegas, Nev.
- Hospital Medicine 2013, May 16-19, National Harbor, Md.
- Hospital Medicine 2012, April 1-4, San Diego, Calif.
- Hospital Medicine 2011, May 10-13, Dallas, Texas.
- Hospital Medicine 2010, April 8-11, Washington, D.C.
- Hospital Medicine 2009, May 14-17, Chicago, Ill.
- Hospital Medicine 2008, April 3-5, San Diego, Calif.
- Hospital Medicine 2007, May 23-25, Dallas, Texas
- Hospital Medicine 2006, May 3-5, Washington, D.C.
Meetings Archive For SHM Converge 2026..
Abstract Number: 792
SHM Converge 2026
Background: Gastrointestinal (GI) malignancies are a leading cause of cancer mortality accounting for ~28% of cancer deaths in the U.S. [1]. Perforation, peritonitis, and septic shock are severe complications often presenting later in the disease course and associated with surgery, prolonged hospitalization, and mortality [2]. Social determinants of health (SDOH) including race, socioeconomic status, and [...]
Abstract Number: 793
SHM Converge 2026
Background: Patients living with pain associated conditions often experience a remitting and relapsing course resulting in frequent emergency department (ED) visits and hospitalizations. The optimal approach to management varies between patients and patient- centered therapy should be specific to each patient. However, healthcare fragmentation, distrust, clinician assumptions, and differences in clinician practices all contribute to [...]
Abstract Number: 794
SHM Converge 2026
Background: Acute pancreatitis (AP) is a common cause of hospitalization in the United States. The aim of our study is to investigate the impact of gender on the outcomes of AP in adult patients hospitalized with AP. Methods: We performed a retrospective study of adult patients with AP utilizing the 2020 Nationwide Inpatient Sample (NIS) [...]
Chapter Winner
Abstract Number: 795
SHM Converge 2026
Background: Patient-directed discharge – defined as leaving the hospital prior to completing recommended medical treatment – is associated with increased morbidity and mortality and occurs in 10-20% of hospitalizations for patients with opioid use disorder (OUD). Patients with OUD often cite untreated pain and withdrawal as contributing to their decision to leave the hospital by [...]
Abstract Number: 796
SHM Converge 2026
Background: Hepatorenal syndrome-acute kidney injury (HRS-AKI), characterized by rapid deterioration in renal function, is a serious complication of decompensated cirrhosis and is associated with significant morbidity and mortality. While terlipressin is the only FDA-approved treatment in the U.S. for adults with HRS-AKI, real-world evidence on its use and outcomes remains limited. We conducted a retrospective [...]
Abstract Number: 797
SHM Converge 2026
Background: As bedside procedure services become more prevalent and their impact on patient satisfaction and length of stay become evident, the volume of procedures expected of services rises. These procedures require assistance from a bedside nurse for consent, patient positioning, medication administration, and lab acquisition. This pulls nurses away from their duties to other patients [...]
Abstract Number: 798
SHM Converge 2026
Background: Acute pancreatitis is a common gastrointestinal condition associated with significant morbidity and healthcare utilization. Hospital at Home (HaH) programs have emerged as an alternative to traditional brick-and-mortar (B&M) hospitalization, offering hospital-level care in the home setting. While HaH has demonstrated feasibility for various conditions, clinical characteristics and outcomes for pancreatitis patients managed by HaH [...]
Abstract Number: 800
SHM Converge 2026
Background: Vitamin K is frequently administered in cirrhosis to correct elevated INR, yet its efficacy and clinical benefit remain uncertain. We systematically reviewed and synthesized its effect on INR, responder rates, and bleeding outcomes. Methods: PubMed/PMC were searched through September 2025. Eligible studies included cirrhotic patients receiving vitamin K with reported INR or bleeding outcomes. [...]
Abstract Number: 801
SHM Converge 2026
Background: In 2025, CMS implemented a new inpatient quality measure to report on age-friendly care, the 4Ms Framework: what matters, medications, mentation, and mobility. Hospitalization at Home (HaH) provides hospital-level care to patients in the comfort of their own homes. This study assesses whether HaH delivers age-friendly care aligned with the 4Ms Framework. Methods: We [...]
Abstract Number: 802
SHM Converge 2026
Background: Patients with liver disease have complex hemostatic abnormalities that can cause severe hematologic complications. Although they are known to be at increased risk for bleeding, newer evidence has dispelled the notion that they are protected from venous thromboembolism (VTE). Liver disease is also associated with multiple complications, such as varices, ascites, and hepatic encephalopathy, [...]